PTGX 8-K 2026-11-05

Protagonist Therapeutics, Inc (PTGX) 8-K dated 2026-11-05 — accession 0001104659-26-123351.

Protagonist Therapeutics, Inc (PTGX) is a biotechnology company listed on NASDAQ.

Protagonist Therapeutics, Inc filed a 8-K on 2026-11-05. Accession 0001104659-26-123351.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported PTGX revenue for 2025-12-31 was $46.0M. Net income was -$130.1M. Revenue was down 89.4% from 2024-12-31 to 2025-12-31. PTGX currently screens at market cap $7.25B.

Not investment advice. The PTGX SEC hub lists recent forms. The stock page is the research view.